Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8841)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Isakov V, Nikitin I, Chulanov V, Ogurtsov P, Lukyanova E, Long J, Wahl J, Helmond FA, The P08160 Trial Investigators. Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia. World J Hepatol 2016; 8(6): 331-339 [PMID: 26962399 DOI: 10.4254/wjh.v8.i6.331] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i6/331.htm |
| Number | Citing Articles |
| 1 |
Vasily Isakov, Dzmitry Paduta, Rolando M. Viani, Jeffrey V. Enejosa, Viktor Pasechnikov, Olga Znoyko, Pavel Ogurtsov, Pavel O. Bogomolov, Marina V. Maevskaya, Xiaotian Chen, Nancy S. Shulman. Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV). European Journal of Gastroenterology & Hepatology 2018; 30(9): 1073 doi: 10.1097/MEG.0000000000001166
|
| 2 |
Vasily Isakov, Vladimir Chulanov, Dzhamal Abdurakhmanov, Eduard Burnevich, Elena Nurmukhametova, Galina Kozhevnikova, Natalya Gankina, Sergey Zhuravel, Svetlana Romanova, Robert H. Hyland, Sophia Lu, Evguenia S. Svarovskaia, John McNally, Diana M. Brainard, Vladimir Ivashkin, Vyacheslav Morozov, Igor Bakulin, Martin Lagging, Konstantin Zhdanov, Ola Weiland. Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden. Infectious Diseases 2019; 51(2): 131 doi: 10.1080/23744235.2018.1535186
|
| 3 |
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012143.pub2
|
| 4 |
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews 2017; 2017(9) doi: 10.1002/14651858.CD012143.pub3
|